Source: Annual Congress 2011 - Smoking cessation science
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Tonnesen, H. Lauri, R. Perfekt, A. Batra, K. Mann (Copenhagen, Denmark; Helsingborg, Sweden; Mannheim, Tübingen, Germany). Efficacy and safety of a novel nicotine mouth spray in smoking cessation: A randomized, placebo-controlled, double blind, multicenter study with 52-week follow up. Eur Respir J 2011; 38: Suppl. 55, 194

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial}, Source: Eur Respir J 2012; 40: 548-554 Year: 2012 A multicenter, randomised, double-blind, placebo-controlled 6 month trial to evaluate efficacy and tolerability of bupropion hydrochloride sustained release (SR) tablets as treatment for nicotine dependency in healthcare workers and as an aid to smoking Source: Eur Respir J 2002; 20: Suppl. 38, 611s Year: 2002 A multicenter, randomized, double-blind, double-dummy, 2-way crossover, single dose study, comparing the efficacy and safety of the fluticasone/salmeterol (500/50 μg) combination administered with the new Elpenhaler inhalation device versus the innovative one in patients with asthma Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009 Omalizumab efficacy following cat allergen exposure: Results from a randomized, double-blind, placebo-controlled, parallel-group study in patients with moderate asthma Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Chinese herbs in treatment of influenza: A multi-centre, randomized, double-blind, placebo-controlled trial Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections Year: 2010 Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial Source: ERJ Open Res, 7 (4) 00475-2021; 10.1183/23120541.00475-2021 Year: 2021 Efficacy and safety of revefenacin (REV), a long-acting muscarinic antagonist for nebulization: results of replicate randomized, double-blind, placebo-controlled, parallel-group phase 3 trials in participants with moderate to very severe COPD Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017 Short-term effect of a single dose of inhaled procaterol on exercise performance in COPD: a randomized, double blind, placebo-controlled, crossover trial Source: Annual Congress 2008 - Physiological response to exercise performance Year: 2008 Open-label, randomized, comparative trail of the efficacy of the azithromycin in the 8-week treatment of mild-to-moderate asthma Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment Year: 2007 Preliminary results of a double-blind placebo-controlled cross-over trial of air cleaning devices for secondary prevention of asthma in hairdressers Source: Eur Respir J 2006; 28: Suppl. 50, 700s Year: 2006 Effectiveness of influenza vaccination in asthmatic children: randomised, double-blind, placebo-controlled trial Source: Eur Respir J 2002; 20: Suppl. 38, 146s Year: 2002 RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations Source: Virtual Congress 2021 – ALERT: COPD Year: 2021 The efficacy and safety of topical phenylephrine before flexible bronchoscopy: a double-blind, randomized controlled trial Source: Annual Congress 2008 - News from diagnostic bronchoscopy Year: 2008 Late Breaking Abstract - Efficacy and safety of eliapixant in refractory chronic cough: Results of the PAGANINI 12-week, randomized, placebo-controlled Phase 2b study Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 A randomized, double-blind, placebo-controlled study to evaluate the role of formoterol in management of acute asthma Source: Eur Respir J 2006; 28: Suppl. 50, 498s Year: 2006 Eszopiclone improves the quality of polysomnography: prospective, blinded, placebo-controlled trial Source: Annual Congress 2008 - Assessment of sleep apnoea Year: 2008 Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021 The safety and immunogenicity of a conjugated nicotine vaccine: results from a double-blind, placebo-controlled trial in healthy smokers and non-smokers Source: Annual Congress 2004 - Update on smoking related damage and cessation Year: 2004 A randomized double-blind placebo-controlled trial on the short and long-term effects of electro acupuncture on moderate to severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 502s Year: 2006